Literature DB >> 25363855

Optic nerve head tubercular granuloma successfully treated with anti-VEGF intravitreal injections in addition to systemic therapy.

Alessandro Invernizzi1, Fabio Franzetti, Francesco Viola, Luca Meroni, Giovanni Staurenghi.   

Abstract

PURPOSE: To describe a case of optic nerve head tubercular granuloma, unresponsive to conventional therapy (antitubercular drugs and systemic steroids), successfully treated with anti-vascular endothelial growth factor (VEGF) intravitreal injections in addition to systemic drugs.
METHODS: Case report.
RESULTS: A 44-year-old patient was referred to our clinic for progressive vision decrease in his left eye during the preceding 4 months. A large granuloma infiltrating optic nerve head was visible at funduscopic examination along with diffuse intraocular inflammation. Workup for granulomatous uveitis supported the diagnosis of presumed intraocular tuberculosis. However, the large granulomatous lesion did not show a good response to conventional therapy for tubercular uveitis (antitubercular drugs and systemic steroids). Anti-VEGF (bevacizumab) intravitreal injections were performed as an adjunct to the ongoing therapy. After 2 injections, the patient showed an almost complete regression of the lesion (demonstrated by optical coherence tomography) and a restoration of vision.
CONCLUSIONS: Anti-VEGF intravitreal injections should be considered in the treatment of large tubercular granulomatous lesions in addition to conventional systemic therapy. Optical coherence tomography could be a suitable tool for studying and following optic nerve head granulomas.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25363855     DOI: 10.5301/ejo.5000528

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  5 in total

1.  Management of optic disc granuloma in a patient of miliary tuberculosis with intravitreal ranibizumab in addition to antitubercular therapy.

Authors:  Pooja Bansal; Ritesh Narula
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

2.  Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  PLoS One       Date:  2022-05-25       Impact factor: 3.752

3.  Anti-VEGF therapy for central retinal vein occlusion caused by tuberculosis-associated uveitis: a case report.

Authors:  Manzo Taguchi; Yutaka Sakurai; Takayuki Kanda; Masaru Takeuchi
Journal:  Int Med Case Rep J       Date:  2017-04-18

4.  Cytokine Biomarkers Associated with Human Extra-Pulmonary Tuberculosis Clinical Strains and Symptoms.

Authors:  Paulo Ranaivomanana; Mihaja Raberahona; Sedera Rabarioelina; Ysé Borella; Alice Machado; Mamy J De Dieu Randria; Rivo A Rakotoarivelo; Voahangy Rasolofo; Niaina Rakotosamimanana
Journal:  Front Microbiol       Date:  2018-02-21       Impact factor: 5.640

Review 5.  Etiopathogenesis, Challenges and Remedies Associated With Female Genital Tuberculosis: Potential Role of Nuclear Receptors.

Authors:  Shalini Gupta; Pawan Gupta
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.